Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY 10605.
Published September 14, 2016 · Recall initiated: August 10, 2016
Summary
FDA records drug Class II recall D-1498-2016, published September 14, 2016 and initiated August 10, 2016. Recalling firm: Allergy Laboratories, Inc.; Status: Terminated; Reported quantity: 1,928,075 vials; Lot: Lot #s: 102814, 102914, 103014, 103114, Exp 10/16; 110314, 110414, 110514, 110614, 110714, 111014, Exp 11/16; 121014, 121114, 121214, 121514, Exp 12/16; 011415, 011515, 011615, 012015, 012115, Exp 01/17; 021315, 021715, 021815, 021915, 022015, Exp 02/17; 030415, 030515, 030615, 031015, 031715, Exp 03/17; 042415, 042815, 042915, 043015, Exp 04/17; 050115, 050515, 052815, 052915, Exp 05/17; 060315, 060415, 061615, 061715, Exp 06/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Allergy Laboratories, Inc.
- Distributor
- Nationwide
- Lot
- Lot #s: 102814, 102914, 103014, 103114, Exp 10/16; 110314, 110414, 110514, 110614, 110714, 111014, Exp 11/16; 121014, 121114, 121214, 121514, Exp 12/16; 011415, 011515, 011615, 012015, 012115, Exp 01/17; 021315, 021715, 021815, 021915, 022015, Exp 02/17; 030415, 030515, 030615, 031015, 031715, Exp 03/17; 042415, 042815, 042915, 043015, Exp 04/17; 050115, 050515, 052815, 052915, Exp 05/17; 060315, 060415, 061615, 061715, Exp 06/17
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOndansetron Injection USP 40 mg/20 mL (2 mg/mL), Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALSSeptember 14, 2016
- FDAMaytag Blue cheese cut and wrapped in clear plastic wrap at store level, sold in various sizes (approximatelySeptember 14, 2016
- FDAEptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only,September 14, 2016
- FDAProduct label reads in part: "Maga PANCAKES DE AVENA***OATMEAL PANCAKES***Peso Neto/Net Weight 16 ozSeptember 14, 2016
- FDALinezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., NorthSeptember 14, 2016
- FDAProduct label reads in part: "Maga PANCAKES INTEGRAL BLANCO***WHITE WHOLE GRAIN PANCAKES***Peso Neto/NetSeptember 14, 2016
Questions about this recall
Was Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY 10605. recalled?
Yes. FDA published recall D-1498-2016 on September 14, 2016. Reported hazard: Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone